ReviewJournal of experimental orthopaedics2025
Suture-augmented primary anterior cruciate ligament repair with internal brace shows acceptable re-rupture rates, favourable outcomes and high return-to-sport rates: A systematic review.
Review in Journal of experimental orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Does combined ACL primary augmentation with autograft reconstruction reduces risk of failure at 3-years follow-up compared to ACL reconstruction?Journal of experimental orthopaedics · 2026Article
- Durable mid-term survivorship after proximal ACL repair with suture augmentation in a middle-aged cohort: A risk factor analysis.Journal of experimental orthopaedics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To describe the safety, efficacy and clinical outcomes of suture-augmented primary anterior cruciate ligament (ACL) repair with internal bracing. Methods: A systematic review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines; the protocol was registered in the PROSPERO database (registration number: CRD42024573962). A comprehensive search of the PubMed, Embase and Cochrane Library databases up to August 2024 was conducted to identify studies reporting clinical outcomes of suture-augmented ACL repair. Inclusion criteria were a minimum follow-up of 2 years, reporting of re-rupture rates together with complications, or functional outcome scores such as International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome Score (KOOS), Lysholm or Tegner activity scale. Results: Thirteen studies involving 671 patients met the eligibility criteria and were included. The ACL re-rupture rate was 10.6% (95% confidence interval [CI]: 7.4-14.2), and the rate of reoperations unrelated to ACL re-rupture (primarily for hardware removal) was 3.2% (95% CI: 0.9-6.5). The pooled data showed a mean time to reinjury of 1.2 years (95% CI: 1-1.3), and failure occurred at a mean patient age of 19.8 years (95% CI: 14.8-24.8). The mean return to sport was 9.5 months (95% CI: 5.7-13.3). Patient-reported outcome measures included IKDC with a post-operative mean score of 86.9 (95% CI: 83.6-90.1) and KOOS total score of 85 (95% CI: 82.1-88). KT-1000 laxity measurements revealed a mean side-to-side difference of 0.9 mm (95% CI: 0.5-1.3). Conclusion: Suture-augmented primary ACL repair with internal brace shows acceptable clinical results, encouraging functional recovery and re-rupture rates. Internal bracing is not associated with a high rate of complications, suggesting that the technique is safe and appropriate for use in carefully selected patients. However, heterogeneity in the existing studies means that additional high-quality, long-term comparative studies are needed to clarify the indications and reliability of this procedure. Level of Evidence: Level IV, systematic review of studies with LoE I-IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.